Stremmel W, Riedel H D, Niederau C, Strohmeyer G
Department of Medicine, University Hospital, Heinrich-Heine University Düsseldorf, Germany.
Eur J Clin Invest. 1993 Jun;23(6):321-9. doi: 10.1111/j.1365-2362.1993.tb02031.x.
Genetic haemochromatosis is an autosomal recessive inherited iron overload disease. The genetic defect and the underlying metabolic error are not known. Several observations indicate that the 2-4-fold increase of iron absorption is due to a regulatory defect of a membrane iron transport system in duodenal mucosal cells. The key pathophysiologic factor may be the increase of gut-derived non-transferrin bound iron liganded to low-molecular mass organic molecules. A putative membrane carrier protein for non-transferrin bound iron was identified and preliminary data suggest its enrichment in plasma membranes of human mucosal cells as well as in liver and other organs which are affected in genetic haemochromatosis. Cellular accumulation of ionic iron leads to peroxidative decomposition of organelle membrane phospholipids with the consequence of cell degeneration and cell death. Impairment of organ function and structural alterations such as cirrhosis of the liver are clinical manifestations.
遗传性血色素沉着症是一种常染色体隐性遗传的铁过载疾病。其遗传缺陷和潜在的代谢错误尚不清楚。多项观察表明,铁吸收增加2至4倍是由于十二指肠黏膜细胞中膜铁转运系统的调节缺陷所致。关键的病理生理因素可能是与低分子量有机分子结合的肠道来源非转铁蛋白结合铁的增加。一种推测的非转铁蛋白结合铁的膜载体蛋白已被鉴定出来,初步数据表明其在人类黏膜细胞的质膜以及遗传性血色素沉着症所累及的肝脏和其他器官中富集。离子铁的细胞内蓄积导致细胞器膜磷脂的过氧化分解,进而导致细胞变性和死亡。器官功能受损和诸如肝硬化等结构改变是其临床表现。